M
Maret Böhm
Researcher at Garvan Institute of Medical Research
Publications - 25
Citations - 1382
Maret Böhm is an academic researcher from Garvan Institute of Medical Research. The author has contributed to research in topics: Prostate cancer & Prostatectomy. The author has an hindex of 16, co-authored 25 publications receiving 1097 citations.
Papers
More filters
Journal ArticleDOI
Multiparametric Magnetic Resonance Imaging Guided Diagnostic Biopsy Detects Significant Prostate Cancer and could Reduce Unnecessary Biopsies and Over Detection: A Prospective Study
James Thompson,Daniel Moses,Ron Shnier,Phillip Brenner,Warick Delprado,Lee Ponsky,Marley Pulbrook,Maret Böhm,Anne Maree Haynes,Andrew Hayen,Phillip D. Stricker +10 more
TL;DR: The accuracy of multiparametric magnetic resonance imaging for detecting significant prostate cancer before diagnostic biopsy in men with abnormal prostate specific antigen/digital rectal examination was determined and reported by expert radiologists achieved an excellent negative predictive value and a moderate positive predictive value forsignificant prostate cancer.
Journal ArticleDOI
Superior quality of life and improved surgical margins are achievable with robotic radical prostatectomy after a long learning curve: a prospective single-surgeon study of 1552 consecutive cases.
James Thompson,James Thompson,Sam Egger,Maret Böhm,Anne-Maree Haynes,J. A. Matthews,K. Rasiah,Phillip D. Stricker,Phillip D. Stricker +8 more
TL;DR: RARP had a long learning curve with inferior outcomes initially, and then showed progressively superior sexual, early urinary, and pT2 PSM outcomes and similar pT3 PSM and late urinary outcomes.
Journal ArticleDOI
The Diagnostic Performance of Multiparametric Magnetic Resonance Imaging to Detect Significant Prostate Cancer.
James Thompson,P. J. Van Leeuwen,Daniel Moses,Ronald Shnier,Phillip Brenner,W. Delprado,Marley Pulbrook,Maret Böhm,A.M. Haynes,Andrew Hayen,Phillip D. Stricker +10 more
TL;DR: In men with an abnormal prostate specific antigen/digital rectal examination, multiparametric magnetic resonance imaging detected significant prostate cancer with an excellent negative predictive value and moderate positive predictive value.
Journal ArticleDOI
Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
Shoshana B. Ginsburg,Ahmad Algohary,Shivani Pahwa,Vikas Gulani,Lee Ponsky,Hannu J. Aronen,Peter J. Boström,Maret Böhm,Anne Maree Haynes,Phillip Brenner,Warick Delprado,James Thompson,Marley Pulbrock,Pekka Taimen,Robert Villani,Phillip D. Stricker,Ardeshir R. Rastinehad,Ivan Jambor,Anant Madabhushi +18 more
TL;DR: To evaluate in a multi‐institutional study whether radiomic features useful for prostate cancer detection from 3 Tesla (T) multi‐parametric MRI (mpMRI) in the transition zone (TZ) differ from those in the peripheral zone (PZ).
Journal ArticleDOI
The molecular origin and taxonomy of mucinous ovarian carcinoma
Dane Cheasley,Matthew Wakefield,Matthew Wakefield,Georgina L Ryland,Prue E. Allan,Kathryn Alsop,Kathryn Alsop,Kaushalya C. Amarasinghe,Sumitra Ananda,Michael S. Anglesio,George Au-Yeung,George Au-Yeung,Maret Böhm,David D.L. Bowtell,David D.L. Bowtell,Alison Brand,Georgia Chenevix-Trench,Michael Christie,Michael Christie,Yoke Eng Chiew,Michael Churchman,Anna deFazio,Renee Demeo,Rhiannon Dudley,Nicole Fairweather,Clare G Fedele,Clare G Fedele,Sian Fereday,Sian Fereday,Stephen B. Fox,Stephen B. Fox,C. Blake Gilks,Charlie Gourley,Neville F. Hacker,Alison Maree Hadley,Joy Hendley,Gwo-Yaw Ho,Siobhan Hughes,David G. Hunstman,Sally M Hunter,Tom Jobling,Kimberly R. Kalli,Scott H. Kaufmann,Catherine J. Kennedy,Martin Köbel,Cécile Le Page,Jason Li,Richard Lupat,Orla McNally,Jessica N. McAlpine,Anne Marie Mes-Masson,Linda Mileshkin,Diane Provencher,Jan Pyman,Kurosh Rahimi,Simone M Rowley,Carolina Salazar,Goli Samimi,Hugo Saunders,Timothy Semple,Ragwha Sharma,Ragwha Sharma,Alice J. Sharpe,Andrew N. Stephens,Niko Thio,Michelle C. Torres,Nadia Traficante,Nadia Traficante,Zhongyue Xing,Magnus Zethoven,Yoland Antill,Clare L. Scott,Ian G. Campbell,Ian G. Campbell,Kylie L. Gorringe,Kylie L. Gorringe +75 more
TL;DR: It is shown that MOC is distinct from tumors from other sites and supports a progressive model of evolution from borderline precursors to high-grade invasive MOC, and high copy number aberration burden is associated with worse prognosis in MOC.